申请人:LILLY CO ELI
公开号:WO2004094393A1
公开(公告)日:2004-11-04
A novel class of 3-oxo-3H-benzo[d]isoxazole carboxamide compounds is disclosed together with the use of such compounds for inhibiting hepatic lipase and/or endothelial lipase activity for treatment, amelioration or prevention of hepatic lipase and/or endothelial lipase mediated diseases.
本发明揭示了一种新的3-氧代-3H-苯并[d]异嗪羧酰胺类化合物,以及使用这些化合物抑制肝脏脂肪酶和/或内皮脂肪酶活性,以治疗、改善或预防肝脏脂肪酶和/或内皮脂肪酶介导的疾病。